Literature summary for 3.2.1.123 extracted from

Misonou, Y.; Shida, K.; Korekane, H.; Seki, Y.; Noura, S.; Ohue, M.; Miyamoto, Y.
Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells (2009), J. Proteome Res., 8, 2990-3005.

Search for more literature for 3.2.1.123

Application

Application	Comment	Organism
medicine	release of glycans from the ceramide moieties of glycosphingolipids by endoglycoceramidase II treatment in order to analyze structures of glycosphingolipids in normal human colorectal epithelial cells, and characteristic alterations of oligosaccharide structures in malignant transformation	Rhodococcus sp.

Organism

Organism	UniProt	Comment	Textmining
Rhodococcus sp.	-	-	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
glycosphingolipid + H2O	release of glycans from the ceramide moieties of glycosphingolipids by endoglycoceramidase II treatment in order to analyze structures of glycosphingolipids in normal human colorectal epithelial cells, and characteristic alterations of oligosaccharide structures in malignant transformation	Rhodococcus sp.	?	-	?

Synonyms

Synonyms	Comment	Organism
endoglycoceramidase II	-	Rhodococcus sp.

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)